Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin issues like hives, rashes, and chickenpox-like eruptions, with women aged 31-40 being the most affected.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.

COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Hair loss is not clearly linked to COVID-19 vaccination in Egyptians.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

Three different methods were compared for creating Titan cells, a type of fungus cell. The OZ method made the most cells initially, but the number dropped quickly. The EB method also made a lot of cells, but the number also dropped. The AA method made fewer cells, but the number stayed steady. The methods also affected which genes were active in the cells.

Plant bioactive compounds are important for health and can help prevent various diseases.

The pandemic stress may have increased alopecia cases in Bangladesh.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

AGA linked to worse COVID-19 outcomes in men.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Hair loss doesn't affect COVID-19 severity.

Doctors should thoroughly inform hair transplant patients about the procedure, risks, and costs to prevent dissatisfaction and legal issues.